Hatteras Venture Partners names ex-GSK CEO Andrew Witty chairman

• Hatteras Venture Partners named Sir Andrew Witty chairman; he previously led GlaxoSmithKline, later ran UnitedHealth Group.
• Norman “Ned” Sharpless joined as managing director of Hatteras Discovery Innovation; he previously led the National Cancer Institute, later served as acting FDA commissioner.
• Sharpless co-founded G1 Therapeutics, later acquired by Pharmacosmos A/S; he will lead a renewed company-creation strategy at HDI.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hatteras Venture Partners published the original content used to generate this news brief on September 30, 2026, and is solely responsible for the information contained therein.